Tech News Summary:
- Angela Douglas MBE has been appointed as President of the British In Vitro Diagnostics Association (BIVDA), starting her role on 1 December 2023. She has over 42 years of experience in the NHS and has held various high-ranking positions.
- Throughout her career, Douglas has received numerous awards and honors for her service to the NHS, including being recognized as one of the UK’s 50 Most Inspiring Women Leaders by the Health Service Journal. She has also worked on various initiatives and projects related to diagnostics and laboratory development.
- Both BIVDA and Angela Douglas are looking forward to utilizing her expertise and experience to address the diverse opportunities and challenges in the in vitro diagnostics industry. In her role as President, Douglas aims to enhance patient care and increase understanding of the contributions of IVDs to healthcare outcomes.
The British In Vitro Diagnostics Association (BIVDA) has appointed Angela Douglas as its new president, reinforcing the organization’s commitment to driving innovation and excellence in the diagnostics industry.
Angela Douglas brings with her a wealth of experience in the healthcare sector, having previously held leadership roles in various medical technology and diagnostics companies. Her appointment comes at a time when the diagnostics industry is facing unprecedented challenges and opportunities, particularly in the wake of the COVID-19 pandemic.
As the new president of BIVDA, Angela Douglas is poised to lead the organization in its efforts to promote the value of diagnostics and advocate for policies that support the growth and development of the industry. She is determined to work closely with BIVDA’s members, stakeholders, and government bodies to ensure that the UK remains at the forefront of innovation in diagnostics.
In a statement, Angela Douglas expressed her excitement about taking on the role, stating, “I am honored to have been appointed as president of BIVDA and am looking forward to working with the team to support the vital work of the diagnostics industry. I am committed to driving positive change and promoting the importance of diagnostics in improving patient outcomes and healthcare delivery.”
The appointment of Angela Douglas comes at a crucial time for the diagnostics industry, with rapid advancements in technology and an increasing focus on personalized medicine. Her leadership is expected to further solidify BIVDA’s position as a leading voice in the field of diagnostics, ensuring that the industry continues to thrive and contribute to the advancement of healthcare in the UK and beyond.